Schedule 13G ownership disclosure

Arch Therapeutics, Inc.

Security class unavailable · CUSIP: 03939W109

Event date: 2015-10-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,500,961
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-066644
Form type
SC 13G/A
Filer
Arch Therapeutics, Inc.
CIK
CIK 1537561
Filed
Nov 18, 2015
Reporting period
Oct 26, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub